Skip to main content
VCbacked
Log inGet Started

1st Biotherapeutics

Seongnam, South Korea

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

$21.9M raised
Jan 2026
Series D
PharmaceuticalTherapeutics

Top Investors

Ligachem BioWanted Lab PartnersGurum Investment-Double CapitalKorea Investment & SecuritiesShinhan Venture Investment

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about 1st Biotherapeutics

How much funding has 1st Biotherapeutics raised?
1st Biotherapeutics has raised $21.9M in total funding. The most recent round was Series D. The last funding was announced in January 2026.
Who are 1st Biotherapeutics's investors?
1st Biotherapeutics's investors include Ligachem Bio, Wanted Lab Partners, Gurum Investment-Double Capital, Korea Investment & Securities, Shinhan Venture Investment.
Where is 1st Biotherapeutics headquartered?
1st Biotherapeutics is headquartered in Seongnam, South Korea.
What does 1st Biotherapeutics do?
1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.
What stage is 1st Biotherapeutics at?
1st Biotherapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"1st Biotherapeutics — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/1st-biotherapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). 1st Biotherapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/1st-biotherapeutics
Wikipedia (cite web)
{{cite web |title=1st Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/1st-biotherapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Pharmaceutical

View all
Pharvaris
Zug
Aplantex
Montréal$2.1M
Clene Nanomedicine
Salt Lake City
Shuttle Pharmaceuticals
Rockville$3.5M
Quiver Bioscience
Cambridge
Psilera
Tampa$3.0M